Hrastm1.1Ics
Targeted Allele Detail
|
|
| Symbol: |
Hrastm1.1Ics |
| Name: |
Hras proto-oncogene, GTPase; targeted mutation 1.1, Mouse Clinical Institute |
| MGI ID: |
MGI:5763073 |
| Synonyms: |
HRAS p.G12S |
| Gene: |
Hras Location: Chr7:140770839-140773938 bp, - strand Genetic Position: Chr7, 86.48 cM
|
| Alliance: |
Hrastm1.1Ics page
|
|
|
|
| Allele Type: |
|
Targeted (Reporter) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: ES cells containing Hrastm1Xbr were retargeted to introduce a G to A and an A to C substitutions at the first and last bases of codon 12 of exon 1. This results in an amino acid substitution of serine for glycine. Cre-mediated recombination was used to remove the hygro STOP cassette. The final allele contains the G12S mutation and the IRES-beta-geo cassette.
(J:325021)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Hras Mutation: |
29 strains or lines available
|
|
| Original: |
J:325021 Dard L, et al., HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models. J Clin Invest. 2022 Apr 15;132(8):e131053 |
| All: |
2 reference(s) |
|